Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	729	254	417	379	717	319
Market Cap Growth	174.69%	-39.25%	10.13%	-47.15%	124.42%	-14.89%
Enterprise Value	535	5	172	171	477	192
Last Close Price	11.05	4.70	6.75	7.28	17.69	11.71
PS Ratio	-	3.17	148.77	59.75	37.41	36.21
PB Ratio	3.01	1.04	1.77	1.91	3.39	3.36
P/TBV Ratio	3.67	1.04	1.77	1.91	3.39	3.36
EV/Sales Ratio	-	0.07	61.21	26.99	24.87	21.82
Debt / Equity Ratio	0.04	0.04	0.05	0.07	-	0
Asset Turnover	-	0.31	0.01	0.03	0.11	0.07
Quick Ratio	17.33	22.13	17.44	12.20	11.58	4.33
Current Ratio	17.70	22.63	17.71	12.41	11.77	4.47
Return on Equity (ROE)	-31.21%	-4.07%	-44.84%	-53.53%	-52.72%	-77.68%
Return on Assets (ROA)	-20.63%	-4.78%	-28.56%	-30.36%	-27.79%	-37.30%
Return on Capital Employed (ROCE)	-40.10%	-7.90%	-45.40%	-53.40%	-37.60%	-69.60%
Earnings Yield	-9.76%	-3.84%	-23.33%	-28.99%	-11.28%	-22.17%
FCF Yield	-8.29%	-0.98%	-21.92%	-26.13%	-11.19%	-17.21%
Buyback Yield / Dilution	-0.19%	-1.10%	-36.27%	-27.23%	-39.47%	-129.53%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q